「ac」の検索結果
129件：96～100件目を表示
-
お知らせ | 千寿製薬株式会社
December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann...
https://www.senju.co.jp/english/news/ -
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
gory 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve redne...
https://www.senju.co.jp/english/products/mytearv.html -
Mytear EYETECT | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® EYETECT® For teary eye, foreign body sensation CHARACTERISTICS Mytear EYETECT includes the anti-inflammatory ingredient, pranoprofen [swich OTC Drug], and is effective...
https://www.senju.co.jp/english/products/eyetect.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
SA Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, ...
https://www.senju.co.jp/english/rd/society/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Japan Active, not Recruiting jRCT2031250103 Dr...
https://www.senju.co.jp/english/rd/trial.html